コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 oma, atrial fibrillation, heart failure, and heart valve disease.
2 stin-insufficient mice would manifest viable heart valve disease.
3 enfluramine (Fen), have been associated with heart valve disease.
4 ing mechanistic insights into this prevalent heart valve disease.
5 d provides a potential platform for studying heart valve disease.
6 g organ-level murine models for the study of heart valve disease.
7 o study, due to its importance in congenital heart valve disease.
8 he possibility of preventing the most common heart valve disease.
9 evaluate potential treatments for congenital heart valve diseases.
10 and organ level investigations of semi-lunar heart valve diseases.
11 nknown Origin of bacteremia, 4 points; prior heart Valve disease, 2 points; Auscultation of a heart m
12 ricardium (BP), are widely used for treating heart valve disease, a group of disorders that affects m
14 n of ECM organization is a common feature of heart valve disease and can often be linked to genetic d
15 proportion of patients with previously known heart valve disease and diabetes mellitus significantly
16 ntial of anti-TNF drugs for the treatment of heart valve disease and identify potential therapeutic t
17 ese cells may be important for understanding heart valve disease and may also be applied to current p
18 persistent or recurrent fever, a history of heart valve disease, and S aureus as the causative patho
19 rix remodeling genes characteristic of human heart valve disease are observed in juvenile scx(-/-) mi
22 ificant variation in treatment and course of heart valve disease (HVD) exists, and outcome measuremen
24 lopmental mechanisms are redeployed in adult heart valve disease, in cardiac fibrosis, and in myocard
29 uring the operative management of left-sided heart valve disease, particularly in the setting of mitr
31 lure, coronary artery disease, heart attack, heart valve disease, stroke, transient ischemic attack (
32 ound Mitral valve prolapse (MVP) is a common heart valve disease, the most frequent indication for va
34 n an individual basis, patients with organic heart valve disease who are trying to delay or avoid sur